HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 202 filers reported holding HEALTH CATALYST INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,831,000 | -49.1% | 2,127,726 | -8.2% | 0.03% | -37.0% |
| Q1 2022 | $60,569,000 | -31.9% | 2,317,997 | +3.3% | 0.05% | -24.6% |
| Q4 2021 | $88,913,000 | -17.7% | 2,244,145 | +3.9% | 0.06% | -20.8% |
| Q3 2021 | $108,016,000 | +0.6% | 2,159,896 | +11.7% | 0.08% | +2.7% |
| Q2 2021 | $107,341,000 | +17.6% | 1,933,719 | -0.9% | 0.08% | +10.3% |
| Q1 2021 | $91,305,000 | +8.1% | 1,952,223 | +0.7% | 0.07% | +4.6% |
| Q4 2020 | $84,425,000 | +39.6% | 1,939,464 | +17.4% | 0.06% | +25.0% |
| Q3 2020 | $60,457,000 | +52.8% | 1,651,820 | +21.8% | 0.05% | +44.4% |
| Q2 2020 | $39,565,000 | +49.6% | 1,356,374 | +34.1% | 0.04% | +24.1% |
| Q1 2020 | $26,453,000 | +68.9% | 1,011,568 | +120.4% | 0.03% | +123.1% |
| Q4 2019 | $15,658,000 | +54.2% | 459,032 | +43.0% | 0.01% | +44.4% |
| Q3 2019 | $10,155,000 | – | 320,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,574,175 | $15,930,651 | 10.16% |
| First Light Asset Management, LLC | 2,930,144 | $29,653,057 | 2.82% |
| Nepsis Inc. | 905,804 | $9,166,736 | 2.81% |
| Granahan Investment Management | 1,177,903 | $11,920,378 | 0.42% |
| Rhenman & Partners Asset Management AB | 320,000 | $3,238,400 | 0.35% |
| Bares Capital Management | 700,000 | $7,084,000 | 0.30% |
| PIER 88 INVESTMENT PARTNERS LLC | 101,470 | $1,026,876 | 0.26% |
| Counterpoint Mutual Funds LLC | 24,086 | $243,750 | 0.20% |
| Brendel Financial Advisors LLC | 11,831 | $120 | 0.18% |
| CVS HEALTH Corp | 32,273 | $326,598 | 0.18% |